Sangamo Therapeutics (SGMOQ) Cash & Equivalents (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted quarterly Cash & Equivalents of $20.9 million for Q4 2025, down 50.03% year-over-year from $41.9 million in Q4 2024, and down 29.27% quarter-over-quarter from $29.6 million in Q3 2025.
Sangamo Therapeutics (SGMOQ) Cash & Equivalents (2010 - 2025) Analysis & Trends
Sangamo Therapeutics' Cash & Equivalents history runs 16 years deep, the most recent figure standing at $20.9 million for Q4 2025.
- In Q4 2025, Cash & Equivalents fell 50.03% year-over-year to $20.9 million; the TTM figure through Dec 2025 stood at $20.9 million (down 50.03% YoY), while the FY2025 annual figure was $20.9 million, down 50.03% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $20.9 million, down from $29.6 million in the prior quarter.
- The five-year high for Cash & Equivalents was $178.9 million in Q4 2021, with the low at $20.9 million in Q4 2025.
- The 5-year median for Cash & Equivalents is $61.7 million (2023), against an average of $80.3 million.
- Peak annual rise in Cash & Equivalents reached 43.41% in 2021, while the deepest fall reached 63.66% in 2021.
- Sangamo Therapeutics' Cash & Equivalents stood at $178.9 million in 2021, then tumbled by 43.85% to $100.4 million in 2022, then plunged by 55.0% to $45.2 million in 2023, then dropped by 7.27% to $41.9 million in 2024, then sank by 50.03% to $20.9 million in 2025.
- Business Quant data shows SGMOQ's Cash & Equivalents at $20.9 million in Q4 2025, $29.6 million in Q3 2025, and $38.3 million in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.95 Mn |
| Sep 30, 2025 | 29.62 Mn |
| Jun 30, 2025 | 38.34 Mn |
| Mar 31, 2025 | 25.20 Mn |
| Dec 31, 2024 | 41.92 Mn |
| Sep 30, 2024 | 39.20 Mn |
| Jun 30, 2024 | 27.79 Mn |
| Mar 31, 2024 | 54.42 Mn |
| Dec 31, 2023 | 45.20 Mn |
| Sep 30, 2023 | 56.51 Mn |
| Jun 30, 2023 | 66.83 Mn |
| Mar 31, 2023 | 78.24 Mn |
| Dec 31, 2022 | 100.44 Mn |
| Sep 30, 2022 | 94.57 Mn |
| Jun 30, 2022 | 117.71 Mn |
| Mar 31, 2022 | 120.26 Mn |
| Dec 31, 2021 | 178.87 Mn |
| Sep 30, 2021 | 176.95 Mn |
| Jun 30, 2021 | 169.88 Mn |
| Mar 31, 2021 | 122.98 Mn |